Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes Noverr MC; Erb-Downward JR; Huffnagle GBClin Microbiol Rev  2003[Jul]; 16 (3): 517-33Oxylipins are oxygenated metabolites of fatty acids. Eicosanoids are a subset of  oxylipins and include the prostaglandins and leukotrienes, which are potent  regulators of host immune responses. Host cells are one source of eicosanoids and  oxylipins during infection; however, another potential source of eicosanoids is  the pathogen itself. A broad range of pathogenic fungi, protozoa, and helminths  produce eicosanoids and other oxylipins by novel synthesis pathways. Why do these  organisms produce oxylipins? Accumulating data suggest that phase change and  differentiation in these organisms are controlled by oxylipins, including  prostaglandins and lipoxygenase products. The precise role of pathogen-derived  eicosanoids in pathogenesis remains to be determined, but the potential link  between pathogen eicosanoids and the development of TH2 responses in the host is  intriguing. Mammalian prostaglandins and leukotrienes have been studied  extensively, and these molecules can modulate Th1 versus Th2 immune responses,  chemokine production, phagocytosis, lymphocyte proliferation, and leukocyte  chemotaxis. Thus, eicosanoids and oxylipins (host or microbe) may be mediators of  a direct host-pathogen "cross-talk" that promotes chronic infection and  hypersensitivity disease, common features of infection by eukaryotic pathogens.|Animals[MESH]|Eicosanoids/*biosynthesis[MESH]|Eukaryota/*metabolism[MESH]|Fungi/*metabolism[MESH]|Helminthiasis/metabolism[MESH]|Helminths/metabolism[MESH]|Mycoses/metabolism[MESH]|Protozoan Infections/metabolism[MESH] |